Stocks-VIR-Vir Biotechnology Inc

VIR Vir Biotechnology Inc

30.85 0.86 (2.87%)
Delayed Prices By NASDAQ, in USD Market Closed
Invest
Stocks-VIR-Vir Biotechnology Inc
VIR Vir Biotechnology Inc
Invest
15.02% Past Week
Created with Highcharts 4.2.7 /Highstock 4.2.7
Market Cap
4.11B
Dayโ€™s Range
29.85
-
31.48
52W Range
18.03
-
35.38
Volume (3M)
843.15K
Price-Earnings Ratio
3.63
Revenue
2.38B

Vir Biotechnology Inc Latest News

View All
Benzinga's Top Ratings Upgrades, Downgrades For January 27, 2023Benzinga's Top Ratings Upgrades, Downgrades For January 27, 2023Benzinga3 days agoVir Biotechnology Taps Bayer Pharmaceuticals Executive for CEOVir Biotechnology Taps Bayer Pharmaceuticals Executive for CEOMarketWatch5 days agoVir Biotechnology, Inc.: Vir Biotechnology Announces Retirement of CEO George Scangos, Ph.D.; Appoints Marianne De Backer, MSc, Ph.D., MBA, as SuccessorVir Biotechnology, Inc.: Vir Biotechnology Announces Retirement of CEO George Scangos, Ph.D.; Appoints Marianne De Backer, MSc, Ph.D., MBA, as SuccessorFinanz Nachrichten5 days ago
Pinned Post
eToro Team
eToro
6 days ago
๐ŸŽ‰ Hereโ€™s a little preview introducing 16 YEARS of INVESTING on eToro ๐Ÿ˜๐Ÿค‘ With love, - The eToro Team youtu.be/UFYvpJxh2qA
How can eToro celebrate 16 years of Investing?
youtu.be
Celebrating 16 years of investing together ๐Ÿ’š #etoro16
Like CommentShare
Show more comments2 of 52
5 replies
1 reply
null
.
Top Discussions
Nikolaos Zervos
Greece
about 20 hours ago
There is an interesting survey titled: โ€œAAII sentiment surveyโ€ that gives us the investorsโ€™ expectations about where the market is heading. This report has a 6 months forecasting outlook. Investors in the latest report seem to have turned more neutral and bearish compared to the previous report. Most... Show More
Like CommentShare
null
.
Nikolaos Zervos
Greece
3 days ago
Market analysis: We welcomed the good GDP numbers for the US Economy. GDP rose 2.9% in the forth quarter, beating the expectations and leaving a bullish sign for the economy. However the picture is still mixed. For starters, we have very tight labour supply. This means that there is more demand than... Show More
Like CommentShare
null
.
Justin Crowhurst
United Kingdom
24 days ago
The Magic Formula stocks should outperform the general stock market. What is it? Does it still work today? Our free review & analysis.. Seems to be mixed opinions on the effectiveness of it over the last few years. moneysandi.com/beating-the-market-with-the-magic-formula-investing-strategy/ Generated... Show More
Beating The Market With The Magic Formula Investing Strategy
moneysandi.com
The Magic Formula stocks should outperform the general stock market. What is it? Does it still work today? Our free review & analysis.
Like CommentShare
null
.
Bjorn Crienen
Netherlands
26 days ago
A well needed break. Hello everyone! As you can I see by the title of the post I am planning to take a sizeable break. I will however keep researching and adding stocks that seem fit for our portfolio. Copiers are unaffected by this change and can/ are more than welcome to ask questions and ask for... Show More
Like CommentShare
Show more comments2 of 6
1 reply
null
.
david bumpstead
United Kingdom
27 days ago
๐™‹๐™€๐™๐™๐™Š๐™๐™ˆ๐˜ผ๐™‰๐˜พ๐™€ ๐™๐™€๐™‘๐™„๐™€๐™’ - ๐™Œ๐Ÿฐ & ๐™๐™” ๐Ÿฎ๐Ÿฌ๐Ÿฎ๐Ÿฎ Dear Copiers and Followers, As we conclude Q4 and the full year of 2022 we will be taking a deeper dive into our portfolio's performance compared to the usual weekly and monthly reviews. This quarterly review is broken down into 3 components: -... Show More
Like CommentShare

About Vir Biotechnology Inc

Founded in 2016, Vir Biotechnology is a clinical-stage immunology company. It works to develop therapeutic products designed to treat and prevent a range of serious infectious diseases. Operating internationally, the company has headquarters in San Francisco, California. It is listed on the NASDAQ GS stock market with the VIR ticker. Add this stock to your eToro watchlist to follow VIR share price movements.
444
Employees
San Francisco, California, US
HQ
2016
Founded
George A. Scangos, PhD
CEO
Show More
Med TechNASDAQ

Upcoming Earnings

23
FEB
REPORTS
Vir Biotechnology Inc Q4 2022 earnings report is expected to be released after market open

ESG: A New Source of Insight

What is an ESG Score?
This number is a measure of a companyโ€™s exposure to environmental, social, and governance risks. Influencing factors include energy efficiency, safety, social policies, and more. Learn More
Powered by ESG Book
Get insight into a company's sustainability using ESG (environmental, social, and governance) scores.
0
100
43
Low
Industry 
Avg. 45 
36
Environment
37
Social
53
Governance

People Also Bought